28 May 2014 --- Nestlé said it will pay $1.4 billion for the rights to a handful of skin-care products from Valeant Pharmaceuticals, in a move that will bolster the Swiss food giant's newly established dermatology unit. Nestle will acquire the U.S. and Canadian commercial rights to five aesthetic dermatology products from Valeant. The U.S. and Canada represent more than half of the global market for medical aesthetics products.
